Page last updated: 2024-09-02

fingolimod hydrochloride and rotenone

fingolimod hydrochloride has been researched along with rotenone in 1 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(rotenone)
Trials
(rotenone)
Recent Studies (post-2010) (rotenone)
2,7711572,0624,40761,648

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)rotenone (IC50)
Bile salt export pumpHomo sapiens (human)8
NADH-ubiquinone oxidoreductase chain 1Bos taurus (cattle)0.015
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrialBos taurus (cattle)0.0051
Cytochrome P450 2C19Homo sapiens (human)3.6486
5-hydroxytryptamine receptor 6Homo sapiens (human)0.87
Acyl carrier protein, mitochondrialBos taurus (cattle)0.0051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, M; Liu, Q; Wood, K; Yang, L; Yang, X; Zhao, P; Zhu, X1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and rotenone

ArticleYear
Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:1

    Topics: Animals; Cell Line, Tumor; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Male; Mice; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, Lysosphingolipid; Rotenone; Sphingosine-1-Phosphate Receptors

2017